Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).

Loebinger MR, Polverino E, Blasi F, Elborn SJ, Chalmers JD, Tiddens HA, Goossens H, Tunney M, Zhou W, Angyalosi G, Hill AT, Haworth CS; iBEST-1 Trial Team.

Pulm Pharmacol Ther. 2019 Aug 18:101834. doi: 10.1016/j.pupt.2019.101834. [Epub ahead of print]

PMID:
31433997
2.

Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough.

Meerburg JJ, Albasri M, van der Wiel EC, Andrinopoulou ER, van der Eerden MM, Majoor CJ, Arets HGM, Heijerman HGM, Tiddens HAWM.

Pediatr Pulmonol. 2019 Aug 8. doi: 10.1002/ppul.24467. [Epub ahead of print]

PMID:
31393073
3.

Lung function in school-aged congenital diaphragmatic hernia patients; a longitudinal evaluation.

Toussaint-Duyster LCC, van der Cammen-van Zijp MHM, Spoel M, Tiddens HAWM, Tibboel D, Wijnen RMH, van Rosmalen J, IJsselstijn H.

Pediatr Pulmonol. 2019 Aug;54(8):1257-1266. doi: 10.1002/ppul.24375. Epub 2019 Jun 13.

PMID:
31197981
4.

Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.

Scholte BJ, Horati H, Veltman M, Vreeken RJ, Garratt LW, Tiddens HAWM, Janssens HM, Stick SM; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF).

J Cyst Fibros. 2019 Apr 25. pii: S1569-1993(19)30071-2. doi: 10.1016/j.jcf.2019.04.011. [Epub ahead of print]

PMID:
31031161
5.

The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis.

Rosenow T, Mok LC, Turkovic L, Berry LJ, Sly PD, Ranganathan S, Tiddens HAWM, Stick SM.

Eur Respir J. 2019 Jul 11;54(1). pii: 1801771. doi: 10.1183/13993003.01771-2018. Print 2019 Jul.

PMID:
31023850
6.

Magnetic resonance imaging of the larynx in the pediatric population: A systematic review.

Elders BBLJ, Hermelijn SM, Tiddens HAWM, Pullens B, Wielopolski PA, Ciet P.

Pediatr Pulmonol. 2019 Apr;54(4):478-486. doi: 10.1002/ppul.24250. Epub 2019 Jan 25. Review.

7.

Technical challenges of quantitative chest MRI data analysis in a large cohort pediatric study.

Nguyen AH, Perez-Rovira A, Wielopolski PA, Hernandez Tamames JA, Duijts L, de Bruijne M, Aliverti A, Pennati F, Ivanovska T, Tiddens HAWM, Ciet P.

Eur Radiol. 2019 Jun;29(6):2770-2782. doi: 10.1007/s00330-018-5863-7. Epub 2018 Dec 5.

8.

Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease.

Chandler JD, Margaroli C, Horati H, Kilgore MB, Veltman M, Liu HK, Taurone AJ, Peng L, Guglani L, Uppal K, Go YM, Tiddens HAWM, Scholte BJ, Tirouvanziam R, Jones DP, Janssens HM.

Eur Respir J. 2018 Oct 10;52(4). pii: 1801118. doi: 10.1183/13993003.01118-2018. Print 2018 Oct.

PMID:
30190273
9.

Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function.

de Winter-de Groot KM, Janssens HM, van Uum RT, Dekkers JF, Berkers G, Vonk A, Kruisselbrink E, Oppelaar H, Vries R, Clevers H, Houwen RHJ, Escher JC, Elias SG, de Jonge HR, de Rijke YB, Tiddens HAWM, van der Ent CK, Beekman JM.

Eur Respir J. 2018 Sep 17;52(3). pii: 1702529. doi: 10.1183/13993003.02529-2017. Print 2018 Sep.

PMID:
30166324
10.

Paediatric lung imaging: the times they are a-changin'.

Tiddens HAWM, Kuo W, van Straten M, Ciet P.

Eur Respir Rev. 2018 Feb 28;27(147). pii: 170097. doi: 10.1183/16000617.0097-2017. Print 2018 Mar 31. Review.

11.

Imaging of respiratory muscles in neuromuscular disease: A review.

Harlaar L, Ciet P, van der Ploeg AT, Brusse E, van der Beek NAME, Wielopolski PA, de Bruijne M, Tiddens HAWM, van Doorn PA.

Neuromuscul Disord. 2018 Mar;28(3):246-256. doi: 10.1016/j.nmd.2017.11.010. Epub 2017 Nov 24. Review.

PMID:
29398294
12.

Reference Values for Central Airway Dimensions on CT Images of Children and Adolescents.

Kuo W, Ciet P, Andrinopoulou ER, Chen Y, Pullens B, Garcia-Peña P, Fleck RJ, Paoletti M, McCartin M, Vermeulen F, Morana G, Lee EY, Tiddens HAWM; Normal Chest CT Study Group.

AJR Am J Roentgenol. 2018 Feb;210(2):423-430. doi: 10.2214/AJR.17.18597. Epub 2017 Dec 20.

PMID:
29261353
13.

Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?

Bos AC, Mouton JW, van Westreenen M, Andrinopoulou ER, Janssens HM, Tiddens HAWM.

J Antimicrob Chemother. 2017 Dec 1;72(12):3435-3442. doi: 10.1093/jac/dkx293.

PMID:
29029057
14.

Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography.

Kuo W, Soffers T, Andrinopoulou ER, Rosenow T, Ranganathan S, Turkovic L, Stick SM, Tiddens HAWM; AREST CF.

Pediatr Pulmonol. 2017 Nov;52(11):1414-1423. doi: 10.1002/ppul.23787. Epub 2017 Sep 7.

PMID:
28881106
15.

Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations.

Grasemann H, Ciet P, Amin R, McDonald N, Klingel M, Tiddens HAWM, Ratjen F, Grosse-Wortmann L.

Eur Respir J. 2017 Aug 24;50(2). pii: 1700244. doi: 10.1183/13993003.00244-2017. Print 2017 Aug. No abstract available.

16.

Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging.

Ciet P, Bertolo S, Ros M, Andrinopoulou ER, Tavano V, Lucca F, Feiweier T, Krestin GP, Tiddens HAWM, Morana G.

Eur Respir J. 2017 Jul 20;50(1). pii: 1601437. doi: 10.1183/13993003.01437-2016. Print 2017 Jul.

17.

Structural and functional ventilatory impairment in infants with severe bronchopulmonary dysplasia.

van Mastrigt E, Kakar E, Ciet P, den Dekker HT, Joosten KF, Kalkman P, Swarte R, Kroon AA, Tiddens HAWM, de Jongste JC, Reiss I, Duijts L, Pijnenburg MW.

Pediatr Pulmonol. 2017 Aug;52(8):1029-1037. doi: 10.1002/ppul.23696. Epub 2017 Jul 3.

PMID:
28672085
18.

Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification.

Kuo W, de Bruijne M, Petersen J, Nasserinejad K, Ozturk H, Chen Y, Perez-Rovira A, Tiddens HAWM.

Eur Radiol. 2017 Nov;27(11):4680-4689. doi: 10.1007/s00330-017-4819-7. Epub 2017 May 18.

19.

Concordance between upper and lower airway microbiota in infants with cystic fibrosis.

Prevaes SM, de Steenhuijsen Piters WA, de Winter-de Groot KM, Janssens HM, Tramper-Stranders GA, Chu ML, Tiddens HA, van Westreenen M, van der Ent CK, Sanders EA, Bogaert D.

Eur Respir J. 2017 Mar 29;49(3). pii: 1602235. doi: 10.1183/13993003.02235-2016. Print 2017 Mar.

20.

Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Schoser B, Fong E, Geberhiwot T, Hughes D, Kissel JT, Madathil SC, Orlikowski D, Polkey MI, Roberts M, Tiddens HA, Young P.

Orphanet J Rare Dis. 2017 Mar 16;12(1):52. doi: 10.1186/s13023-017-0598-0. Review.

21.

The fate of inhaled antibiotics after deposition in cystic fibrosis: How to get drug to the bug?

Bos AC, Passé KM, Mouton JW, Janssens HM, Tiddens HA.

J Cyst Fibros. 2017 Jan;16(1):13-23. doi: 10.1016/j.jcf.2016.10.001. Epub 2016 Oct 26. Review.

22.

Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.

Melki I, Rose Y, Uggenti C, Van Eyck L, Frémond ML, Kitabayashi N, Rice GI, Jenkinson EM, Boulai A, Jeremiah N, Gattorno M, Volpi S, Sacco O, Terheggen-Lagro SWJ, Tiddens HAWM, Meyts I, Morren MA, De Haes P, Wouters C, Legius E, Corveleyn A, Rieux-Laucat F, Bodemer C, Callebaut I, Rodero MP, Crow YJ.

J Allergy Clin Immunol. 2017 Aug;140(2):543-552.e5. doi: 10.1016/j.jaci.2016.10.031. Epub 2017 Jan 10. Erratum in: J Allergy Clin Immunol. 2017 Dec;140(6):1757.

PMID:
28087229
23.

Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HAWM.

J Cyst Fibros. 2017 Mar;16(2):175-185. doi: 10.1016/j.jcf.2016.12.008. Epub 2016 Dec 28. Review.

24.

Automatic airway-artery analysis on lung CT to quantify airway wall thickening and bronchiectasis.

Perez-Rovira A, Kuo W, Petersen J, Tiddens HA, de Bruijne M.

Med Phys. 2016 Oct;43(10):5736.

PMID:
27782697
25.

Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI.

Mogalle K, Perez-Rovira A, Ciet P, Wens SC, van Doorn PA, Tiddens HA, van der Ploeg AT, de Bruijne M.

PLoS One. 2016 Jul 8;11(7):e0158912. doi: 10.1371/journal.pone.0158912. eCollection 2016.

26.

Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung disease.

Kuo W, Andrinopoulou ER, Perez-Rovira A, Ozturk H, de Bruijne M, Tiddens HA.

J Cyst Fibros. 2017 Jan;16(1):116-123. doi: 10.1016/j.jcf.2016.05.015. Epub 2016 Jun 21.

27.

Spirometer guided chest imaging in children: It is worth the effort!

Salamon E, Lever S, Kuo W, Ciet P, Tiddens HA.

Pediatr Pulmonol. 2017 Jan;52(1):48-56. doi: 10.1002/ppul.23490. Epub 2016 Jun 6.

PMID:
27273821
28.

Lung CT imaging in patients with bronchopulmonary dysplasia: A systematic review.

van Mastrigt E, Logie K, Ciet P, Reiss IK, Duijts L, Pijnenburg MW, Tiddens HA.

Pediatr Pulmonol. 2016 Sep;51(9):975-86. doi: 10.1002/ppul.23446. Epub 2016 May 5. Review.

PMID:
27148803
29.

The development of bronchiectasis on chest computed tomography in children with cystic fibrosis: can pre-stages be identified?

Tepper LA, Caudri D, Rovira AP, Tiddens HA, de Bruijne M.

Eur Radiol. 2016 Dec;26(12):4563-4569. Epub 2016 Apr 23.

30.

Multicentre chest computed tomography standardisation in children and adolescents with cystic fibrosis: the way forward.

Kuo W, Kemner-van de Corput MP, Perez-Rovira A, de Bruijne M, Fajac I, Tiddens HA, van Straten M; ECFS-CTN/SCIFI CF study group.

Eur Respir J. 2016 Jun;47(6):1706-17. doi: 10.1183/13993003.01601-2015. Epub 2016 Apr 13.

31.

Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis.

Bos AC, Tiddens HA, Tong Minh K, Heeres I, Overweel-Uijterlinde JL, Kok AE, Andrinopoulou ER, Janssens HM.

J Cyst Fibros. 2016 Sep;15(5):645-51. doi: 10.1016/j.jcf.2016.03.005. Epub 2016 Mar 24.

32.

Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging.

Ciet P, Serra G, Andrinopoulou ER, Bertolo S, Ros M, Catalano C, Colagrande S, Tiddens HA, Morana G.

Eur Radiol. 2016 Nov;26(11):3830-3839. Epub 2016 Feb 12.

PMID:
26873494
33.

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.

van Velzen AJ, Bos AC, Touw DJ, Tiddens HA, Heijerman HG, Janssens HM.

J Aerosol Med Pulm Drug Deliv. 2016 Jun;29(3):273-80. doi: 10.1089/jamp.2015.1259. Epub 2015 Dec 30.

PMID:
26716357
34.

Reply: Excess Risk of Cancer from Computed Tomography Scan Is Small but Not So Low as to Be Incalculable.

Rosenow T, Oudraad MC, Murray CP, Turkovic L, Kuo W, de Bruijne M, Ranganathan SC, Tiddens HA, Stick SM.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1397-9. doi: 10.1164/rccm.201508-1574LE. No abstract available.

PMID:
26623692
35.

Morphometric Analysis of Explant Lungs in Cystic Fibrosis.

Boon M, Verleden SE, Bosch B, Lammertyn EJ, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens HA, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Van Raemdonck DE, Decramer M, Verleden GM, Hogg JC, Dupont LJ, Vanaudenaerde BM, De Boeck K.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):516-26. doi: 10.1164/rccm.201507-1281OC.

PMID:
26551917
36.

Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.

Prevaes SM, de Winter-de Groot KM, Janssens HM, de Steenhuijsen Piters WA, Tramper-Stranders GA, Wyllie AL, Hasrat R, Tiddens HA, van Westreenen M, van der Ent CK, Sanders EA, Bogaert D.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.

PMID:
26492486
37.

Pulmonary ventilation and micro-structural findings in congenital diaphragmatic hernia.

Spoel M, Marshall H, IJsselstijn H, Parra-Robles J, van der Wiel E, Swift AJ, Rajaram S, Tibboel D, Tiddens HA, Wild JM.

Pediatr Pulmonol. 2016 May;51(5):517-24. doi: 10.1002/ppul.23325. Epub 2015 Oct 9.

PMID:
26451536
38.

Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort.

Tepper LA, Ciet P, Caudri D, Quittner AL, Utens EM, Tiddens HA.

Pediatr Pulmonol. 2016 Jan;51(1):34-41. doi: 10.1002/ppul.23328. Epub 2015 Oct 5.

PMID:
26436668
39.

Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imaging.

Ciet P, Tiddens HA, Wielopolski PA, Wild JM, Lee EY, Morana G, Lequin MH.

Pediatr Radiol. 2015 Dec;45(13):1901-15. doi: 10.1007/s00247-015-3420-y. Epub 2015 Sep 5. Review.

40.

Respiratory tract exacerbations revisited: ventilation, inflammation, perfusion, and structure (VIPS) monitoring to redefine treatment.

Tiddens HA, Stick SM, Wild JM, Ciet P, Parker GJ, Koch A, Vogel-Claussen J.

Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S57-65. doi: 10.1002/ppul.23266. Review.

PMID:
26335955
41.

Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT.

Ciet P, Serra G, Bertolo S, Spronk S, Ros M, Fraioli F, Quattrucci S, Assael MB, Catalano C, Pomerri F, Tiddens HA, Morana G.

Eur Radiol. 2016 Mar;26(3):780-7. doi: 10.1007/s00330-015-3850-9. Epub 2015 May 30.

PMID:
26024847
42.

Tracheomalacia in Adults with Cystic Fibrosis: Determination of Prevalence and Severity with Dynamic Cine CT.

McDermott S, Barry SC, Judge EE, Collins S, de Jong PA, Tiddens HA, McKone EF, Gallagher CG, Dodd JD.

Radiology. 2015 Jun;275(3):934. doi: 10.1148/radiol.2015154012. No abstract available.

PMID:
25997140
43.

Lung MRI and impairment of diaphragmatic function in Pompe disease.

Wens SC, Ciet P, Perez-Rovira A, Logie K, Salamon E, Wielopolski P, de Bruijne M, Kruijshaar ME, Tiddens HA, van Doorn PA, van der Ploeg AT.

BMC Pulm Med. 2015 May 6;15:54. doi: 10.1186/s12890-015-0058-3.

44.

Reversibility of trapped air on chest computed tomography in cystic fibrosis patients.

Loeve M, Rosenow T, Gorbunova V, Hop WC, Tiddens HA, de Bruijne M.

Eur J Radiol. 2015 Jun;84(6):1184-90. doi: 10.1016/j.ejrad.2015.02.011. Epub 2015 Feb 21.

PMID:
25840703
45.

PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis.

Rosenow T, Oudraad MC, Murray CP, Turkovic L, Kuo W, de Bruijne M, Ranganathan SC, Tiddens HA, Stick SM; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF).

Am J Respir Crit Care Med. 2015 May 15;191(10):1158-65. doi: 10.1164/rccm.201501-0061OC.

PMID:
25756857
46.

Model of mucociliary clearance in cystic fibrosis lungs.

Kurbatova P, Bessonov N, Volpert V, Tiddens HA, Cornu C, Nony P, Caudri D; CRESim Working Group.

J Theor Biol. 2015 May 7;372:81-8. doi: 10.1016/j.jtbi.2015.02.023. Epub 2015 Mar 5.

PMID:
25746843
47.

Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?

Bos AC, van Holsbeke C, de Backer JW, van Westreenen M, Janssens HM, Vos WG, Tiddens HA.

PLoS One. 2015 Mar 3;10(3):e0118454. doi: 10.1371/journal.pone.0118454. eCollection 2015.

48.

Novel outcome measures for clinical trials in cystic fibrosis.

Tiddens HAWM, Puderbach M, Venegas JG, Ratjen F, Donaldson SH, Davis SD, Rowe SM, Sagel SD, Higgins M, Waltz DA.

Pediatr Pulmonol. 2015 Mar;50(3):302-315. doi: 10.1002/ppul.23146. Epub 2014 Dec 30. Review.

49.

Inhaled antibiotics: dry or wet?

Tiddens HA, Bos AC, Mouton JW, Devadason S, Janssens HM.

Eur Respir J. 2014 Nov;44(5):1308-18. doi: 10.1183/09031936.00090314. Epub 2014 Oct 16. Review.

50.

What did we learn from two decades of chest computed tomography in cystic fibrosis?

Tiddens HA, Rosenow T.

Pediatr Radiol. 2014 Dec;44(12):1490-5. doi: 10.1007/s00247-014-2964-6. Epub 2014 Aug 28. Review.

PMID:
25164327

Supplemental Content

Loading ...
Support Center